Ubs Asset Management Americas Inc Zai Lab LTD Transaction History

Ubs Asset Management Americas Inc

$477 Billion
Q2 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Zai Lab LTD stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 5,250 shares of ZLAB stock, worth $180,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,250

Previous 1,200 337.5%

Holding current value

$180,127

Previous $43,000 325.58%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$24.32 - $43.03 $98,496 - $174,271	4,050 Added 337.5%	5,250 $183,000
Q1 2025 May 19, 2025	SELL	$24.29 - $38.35 $1.36 Million - $2.14 Million	-55,914 Reduced 97.9%	1,200 $43,000
Q4 2024 Feb 14, 2025	BUY	$24.61 - $33.18 $29,532 - $39,816	1,200 Added 2.15%	57,114 $1.5 Million
Q2 2024 Aug 13, 2024	BUY	$13.72 - $21.55 $517,833 - $813,361	37,743 Added 207.71%	55,914 $968,000
Q1 2024 May 15, 2024	BUY	$15.95 - $26.8 $75,044 - $126,094	4,705 Added 34.94%	18,171 $291,000
Q4 2023 Feb 14, 2024	BUY	$22.97 - $30.58 $3,399 - $4,525	148 Added 1.11%	13,466 $368,000
Q3 2023 Nov 13, 2023	SELL	$22.72 - $31.49 $10.1 Million - $14 Million	-444,980 Reduced 97.09%	13,318 $323,000
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $1.27 Million - $2.02 Million	41,965 Added 10.08%	458,298 $15.2 Million
Q4 2022 Feb 14, 2023	SELL	$22.28 - $38.71 $24,953 - $43,355	-1,120 Reduced 0.27%	416,333 $12.8 Million
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $72,538 - $109,634	2,121 Added 0.51%	417,453 $14.3 Million
Q2 2022 Aug 12, 2022	SELL	$23.14 - $49.68 $136,132 - $292,267	-5,883 Reduced 1.4%	415,332 $14.4 Million
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $357,927 - $830,051	-12,889 Reduced 2.97%	421,215 $18.5 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $1.78 Million - $3.42 Million	32,459 Added 8.08%	434,104 $27.3 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $1.94 Million - $3.29 Million	18,435 Added 4.81%	401,645 $42.3 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $2.62 Million - $3.77 Million	20,922 Added 5.77%	383,210 $67.8 Million
Q1 2021 May 14, 2021	BUY	$126.27 - $191.71 $356,712 - $541,580	2,825 Added 0.79%	362,288 $48.3 Million
Q4 2020 Mar 01, 2021	BUY	$81.94 - $135.34 $10.3 Million - $17.1 Million	126,112 Added 54.04%	359,463 $48.6 Million
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $5.52 Million - $6.74 Million	75,286 Added 47.63%	233,351 $19.4 Million
Q2 2020 Aug 14, 2020	BUY	$48.82 - $82.53 $2.89 Million - $4.89 Million	59,265 Added 59.98%	158,065 $13 Million
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $3.86 Million - $6.21 Million	98,800 New	98,800 $5.09 Million

Others Institutions Holding ZLAB

# of Institutions

170

Shares Held

38.6M

Call Options Held

150K

Put Options Held

201K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.36B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Zai Lab LTD Transaction History